New insight into brain disease therapy: nanomedicines-crossing blood–brain barrier and extracellular space for drug delivery

References

• Abbott NJ, Patabendige AA, Dolman DE, et al. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010 Jan;37(1):13–25.
   PubMed Web of Science ®Google Scholar
• Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018 Mar;14(3):133–150.
   PubMed Web of Science ®Google Scholar
• Nicholson C, Hrabětová S. Brain extracellular space: the final frontier of neuroscience. Biophys J. 2017 Nov 21;113(10):2133–2142.
   PubMed Web of Science ®Google Scholar
• Edwards TN, Meinertzhagen IA. The functional organisation of glia in the adult brain of drosophila and other insects. Prog Neurobiol. 2010 Apr;90(4):471–497.
   PubMed Web of Science ®Google Scholar
• Deco G, Rolls ET, Albantakis L, et al. Brain mechanisms for perceptual and reward-related decision-making. Prog Neurobiol. 2013 Apr;103:194–213.
   PubMed Web of Science ®Google Scholar
• Kastellakis G, Cai DJ, Mednick SC, et al. Synaptic clustering within dendrites: an emerging theory of memory formation. Prog Neurobiol. 2015 Mar;126:19–35.
   PubMed Web of Science ®Google Scholar
• Lei Y, Han H, Yuan F, et al. The brain interstitial system: anatomy, modeling, in vivo measurement, and applications. Prog Neurobiol. 2017 Oct;157:230–246.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhou Z, Qian Q, et al. Glutathione-capped fluorescent gold nanoclusters for dual-modal fluorescence/X-ray computed tomography imaging. J Mater Chem B. 2013 Oct 14;1(38):5045–5053.
   PubMed Web of Science ®Google Scholar
• Agrawal M, Ajazuddin, Tripathi DK, et al. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer’s disease. J Control Release. 2017 Aug 28;260:61–77.
   PubMed Web of Science ®Google Scholar
• Singh I, Swami R, Pooja D, et al. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting. J Drug Target. 2016;24(3):212–223.
   PubMed Web of Science ®Google Scholar
• Saesoo S, Sathornsumetee S, Anekwiang P, et al. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma. Colloids Surf B Biointerfaces. 2018 Jan 1;161:497–507.
   PubMed Web of Science ®Google Scholar
• Kong L, Li XT, Ni YN, et al. Transferrin-modified osthole pegylated liposomes travel the blood-brain barrier and mitigate Alzheimer’s disease-related pathology in APP/PS-1 mice. Int J Nanomedicine. 2020;15:2841–2858.
   PubMed Web of Science ®Google Scholar
• Lin CY, Lin YC, Huang CY, et al. Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: preclinical investigation for Parkinson’s disease treatment. J Control Release. 2020 May 10;321:519–528. DOI:10.1016/j.jconrel.2020.02.044.
   PubMed Web of Science ®Google Scholar
• Moon H, Hwang K, Nam KM, et al. Enhanced delivery to brain using sonosensitive liposome and microbubble with focused ultrasound. Biomater Adv. 2022 Sep 6;141:213102. DOI:10.1016/j.bioadv.2022.213102.
   PubMedGoogle Scholar
• Saha S, Yakati V, Shankar G, et al. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma. J Mater Chem B. 2020 May 21;8(19):4318–4330.
   PubMed Web of Science ®Google Scholar
• Salvati E, Re F, Sesana S, et al. Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model. Int J Nanomedicine. 2013;8:1749–1758.
   PubMed Web of Science ®Google Scholar
• Wu S, Yang X. OEA loaded liposomes with the neuroprotective effect for stroke therapy. Front Chem. 2022;10:1014208.
   PubMed Web of Science ®Google Scholar
• Almeida B, Nag OK, Rogers KE, et al. Recent progress in bioconjugation strategies for liposome-mediated drug delivery. Molecules. 2020;25(23):5672.
   PubMed Web of Science ®Google Scholar
• Kapoor DN, Bhatia A, Kaur R, et al. PLGA: a unique polymer for drug delivery. Ther Deliv. 2015 Jan;6(1):41–58.
   PubMed Web of Science ®Google Scholar
• Tabatabaei Mirakabad F S, Nejati-Koshki K, Akbarzadeh A, et al. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 2014;15(2):517–535.
   PubMedGoogle Scholar
• Xu K, An N, Zhang H, et al. Sustained-release of PDGF from PLGA microsphere embedded thermo-sensitive hydrogel promoting wound healing by inhibiting autophagy. J Drug Delivery Sci Technol. 2020;55:101405.
   Web of Science ®Google Scholar
• Cai Q, Qiao C, Ning J, et al. A polysaccharide-based hydrogel and PLGA microspheres for sustained P24 peptide delivery: an in vitro and in vivo study based on osteogenic capability. Chem Res Chin Univ. 2019;35(5):908–915.
   Web of Science ®Google Scholar
• Lu Y, Wu F, Duan W, et al. Engineering a “PEG-g-PEI/DNA nanoparticle-in-PLGA microsphere” hybrid controlled release system to enhance immunogenicity of DNA vaccine. Mater Sci Eng C. 2020;106:110294.
   PubMed Web of Science ®Google Scholar
• Su Y, Zhang B, Sun R, et al. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv. 2021;28(1):1397–1418.
   PubMed Web of Science ®Google Scholar
• Shakeri S, Ashrafizadeh M, Zarrabi A, et al. Multifunctional polymeric nanoplatforms for brain diseases diagnosis, therapy and theranostics. Biomedicines. 2020;8(1):13.
   PubMed Web of Science ®Google Scholar
• Shah SR, Kim J, Schiapparelli P, et al. Verteporfin-loaded polymeric microparticles for intratumoral treatment of brain cancer. Mol Pharm. 2019 Apr 1;16(4):1433–1443.
   PubMedGoogle Scholar
• Cunha A, Gaubert A, Verget J, et al. Trehalose-based nucleolipids as nanocarriers for autophagy modulation: an in vitro study. Pharmaceutics. 2022 Apr 13;14(4).
   Web of Science ®Google Scholar
• Gajbhiye KR, Gajbhiye V, Siddiqui IA, et al. Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: an in vitro-in vivo study. Sci Rep. 2017 Sep 11;7(1):11086.
   PubMedGoogle Scholar
• Gholamzad M, Baharlooi H, Shafiee Ardestani M, et al. Prophylactic and therapeutic effects of MOG-Conjugated PLGA nanoparticles in C57Bl/6 mouse model of multiple sclerosis. Adv Pharm Bull. 2021 May;11(3):505–513.
   PubMed Web of Science ®Google Scholar
• Loureiro JA, Gomes B, Fricker G, et al. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer’s disease treatment. Colloids Surf B Biointerfaces. 2016 Sep 1;145:8–13.
   PubMed Web of Science ®Google Scholar
• Smiley SB, Yun Y, Ayyagari P, et al. Development of CD133 targeting multi-drug polymer micellar nanoparticles for glioblastoma - in vitro evaluation in glioblastoma stem cells. Pharm Res. 2021 Jun;38(6):1067–1079.
   PubMed Web of Science ®Google Scholar
• Mansur HS. Quantum dots and nanocomposites. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(2):113–129.
   PubMed Web of Science ®Google Scholar
• Ekimov AI, Onushchenko AA. Quantum size effect in three-dimensional microscopic semiconductor crystals. ZhETF Pisma Redaktsiiu. 1981;34:363.
   Web of Science ®Google Scholar
• Perini G, Palmieri V, Ciasca G, et al. Unravelling the potential of graphene quantum dots in biomedicine and neuroscience. Int J Mol Sci. 2020;21(10):3712.
   PubMed Web of Science ®Google Scholar
• Edis Z, Wang J, Waqas MK, et al. Nanocarriers-mediated drug delivery systems for anticancer agents: an overview and perspectives. Int J Nanomedicine. 2021;16:1313–1330.
   PubMed Web of Science ®Google Scholar
• Matea CT, Mocan T, Tabaran F, et al. Quantum dots in imaging, drug delivery and sensor applications. Int J Nanomedicine. 2017;12:5421.
   PubMed Web of Science ®Google Scholar
• Díaz-González M, de la Escosura-Muñiz A, Fernandez-Argüelles MT, et al. Quantum dot bioconjugates for diagnostic applications. Top Curr Chem (Cham). 2020 Mar 26;378(2):35.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang Y, Ding J, et al. Synthesis of carbon quantum dots for application of alleviating amyloid-β mediated neurotoxicity. Colloids Surf B Biointerfaces. 2022 Apr;212:112373.
   PubMed Web of Science ®Google Scholar
• Y-P H, Leong KW. Quantum dot-based theranostics. Nanoscale. 2010;2(1):60–68.
   PubMed Web of Science ®Google Scholar
• Sukhanova A, Bozrova S, Gerasimovich E, et al. Dependence of quantum dot toxicity in vitro on their size, chemical composition, and surface charge. Nanomaterials (Basel). 2022 Aug 9;12(16). 10.3390/nano12162734
   Google Scholar
• Liu N, Tang M. Toxicity of different types of quantum dots to mammalian cells in vitro: an update review. J Hazard Mater. 2020 Nov 15;399:122606.10.1016/j.jhazmat.2020.122606
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang T, Tang M. Toxicity of quantum dots on target organs and immune system. J Appl Toxicol. 2022 Jan;42(1):17–40.
   PubMed Web of Science ®Google Scholar
• Li S, Skromne I, Peng Z, et al. “Dark” carbon dots specifically “light-up” calcified zebrafish bones. J Mater Chem B. 2016 Dec 14;4(46):7398–7405.
   PubMed Web of Science ®Google Scholar
• Kresge A, Leonowicz M, Roth WJ, et al. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature. 1992;359(6397):710–712.
   Web of Science ®Google Scholar
• Singh P, Srivastava S, Singh SK. Nanosilica: recent progress in synthesis, functionalization, biocompatibility, and biomedical applications. ACS Biomater Sci Eng. 2019;5(10):4882–4898.
   PubMed Web of Science ®Google Scholar
• IUPAC. Manual of symbols and terminology ApPCaSCPaAC. 1972;31:579–638.
   Google Scholar
• Song Y, Du D, Li L, et al. In vitro study of receptor-mediated silica nanoparticles delivery across blood-brain barrier. ACS Appl Mater Interfaces. 2017 Jun 21;9(24):20410–20416.
   PubMed Web of Science ®Google Scholar
• Pellen-Mussi P, Tricot-Doleux S, Neaime C, et al. Evaluation of functional SiO2 nanoparticles toxicity by a 3D culture model. J Nanosci Nanotechnol. 2018;18(5):3148–3157.
   PubMed Web of Science ®Google Scholar
• Qian ZM, Tang PL. Mechanisms of iron uptake by mammalian cells. Biochim Biophys Acta Mol Cell Res. 1995;1269(3):205–214.
   Web of Science ®Google Scholar
• Z-q Y, Wu Q, Zhou X-M, et al. Receptor-mediated delivery of Astaxanthin-loaded nanoparticles to neurons: an enhanced potential for subarachnoid hemorrhage treatment. Front Neurosci. 2019;13:989.
   PubMed Web of Science ®Google Scholar
• Nilsson KG. Preparation of nanoparticles conjugated with enzyme and antibody and their use in heterogeneous enzyme immunoassays. J Immunol Methods. 1989;122(2):273–277.
   PubMed Web of Science ®Google Scholar
• Ramalho MJ, Loureiro JA, Coelho MAN, et al. Transferrin receptor-targeted nanocarriers: overcoming barriers to treat glioblastoma. Pharmaceutics. 2022 Jan 25;14(2). DOI:10.3390/pharmaceutics14020279.
   Web of Science ®Google Scholar
• Neves A, van der Putten L, Queiroz J, et al. Transferrin-functionalized lipid nanoparticles for curcumin brain delivery. J Biotechnol. 2021;331:108–117.
   PubMed Web of Science ®Google Scholar
• Lan W, Zhang H, Yang B. Preliminary study on the therapeutic effect of doxorubicin-loaded targeting nanoparticles on glioma. Appl Bionics Biomech. 2022;2022. DOI:10.1155/2022/6405400.
   PubMed Web of Science ®Google Scholar
• Loureiro JA, Gomes B, Coelho MA, et al. Targeting nanoparticles across the blood–brain barrier with monoclonal antibodies. Nanomedicine. 2014;9(5):709–722.
   PubMed Web of Science ®Google Scholar
• Kuang Y, An S, Guo Y, et al. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting. Int J Pharm. 2013;454(1):11–20.
   PubMedGoogle Scholar
• Kucharz K, Kristensen K, Johnsen KB, et al. Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles. Nat Commun. 2021 Jul 5;12(1):4121.
   PubMed Web of Science ®Google Scholar
• Johnsen KB, Bak M, Kempen PJ, et al. Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles. Theranostics. 2018;8(12):3416–3436.
   PubMed Web of Science ®Google Scholar
• Johnsen KB, Bak M, Melander F, et al. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo. J Control Release. 2019 Feb 10;295:237–249.
   PubMed Web of Science ®Google Scholar
• Herz J, Hamann U, Rogne S, et al. Surface location and high affinity for calcium of a 500‐kd liver membrane protein closely related to the LDL‐receptor suggest a physiological role as lipoprotein receptor. EMBO J. 1988;7(13):4119–4127.
   PubMed Web of Science ®Google Scholar
• Lillis AP, Van Duyn LB, Murphy-Ullrich JE, et al. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev. 2008;88(3):887–918.
   PubMed Web of Science ®Google Scholar
• Maletínská L, Blakely EA, Bjornstad KA, et al. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res. 2000;60(8):2300–2303.
   PubMed Web of Science ®Google Scholar
• Anami Y, Xiong W, Yamaguchi A, et al. Homogeneous antibody–angiopep 2 conjugates for effective brain targeting. RSC Adv. 2022;12(6):3359–3364.
   PubMed Web of Science ®Google Scholar
• Regina A, Demeule M, Tripathy S, et al. ANG4043, a novel brain-penetrant peptide–mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice. Mol Cancer Ther. 2015;14(1):129–140.
   PubMed Web of Science ®Google Scholar
• Zhang B, Xue R, Sun C. Rational design of ROS-responsive nanocarriers for targeted X-ray-induced photodynamic therapy and cascaded chemotherapy of intracranial glioblastoma. Nanoscale. 2022;14:5054–5067.
   PubMed Web of Science ®Google Scholar
• Fillebeen C, Descamps L, Dehouck MP, et al. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem. 1999 Mar 12;274(11):7011–7017.
   PubMed Web of Science ®Google Scholar
• Qi N, Zhang S, Zhou X, et al. Combined integrin α(v)β(3) and lactoferrin receptor targeted docetaxel liposomes enhance the brain targeting effect and anti-glioma effect. J Nanobiotechnology. 2021 Dec 23;19(1):446.
   PubMed Web of Science ®Google Scholar
• Teixeira MI, Lopes CM, Gonçalves H, et al. Formulation, characterization, and cytotoxicity evaluation of lactoferrin functionalized lipid nanoparticles for riluzole delivery to the brain. Pharmaceutics. 2022;14(1):185.
   PubMed Web of Science ®Google Scholar
• Ahmad F, Sun Q, Patel D, et al. Cholesterol metabolism: a potential therapeutic target in glioblastoma. Cancers (Basel). 2019 Jan 26;11(2). DOI:10.3390/cancers11020146.
   Web of Science ®Google Scholar
• Hong DY, Lee DH, Lee JY, et al. Relationship between brain metabolic disorders and cognitive impairment: LDL receptor defect. Int J Mol Sci. 2022 Jul 29;23(15). DOI:10.3390/ijms23158384.
   Web of Science ®Google Scholar
• Lee J, Pilch PF. The insulin receptor: structure, function, and signaling. Am J Physiol Cell Physiol. 1994;266(2):C319–C334.
   PubMedGoogle Scholar
• Rechler MM, Nissley SP. Insulin-like growth factor (IGF)/somatomedin receptor subtypes: structure, function, and relationships to insulin receptors and IGF carrier proteins. Horm Res. 1986;24(2–3):152–159.
   PubMedGoogle Scholar
• Messier C, Teutenberg K. The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer’s disease. Neural Plast. 2005;12(4):311–328.
   PubMedGoogle Scholar
• Shilo M, Motiei M, Hana P, et al. Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications. Nanoscale. 2014;6(4):2146–2152.
   PubMed Web of Science ®Google Scholar
• Boado RJ, Zhang Y, Zhang Y, et al. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier. Biotechnol Bioeng. 2007 Feb 1;96(2):381–391.
   PubMed Web of Science ®Google Scholar
• Giugliani R, Giugliani L, de Oliveira Poswar F, et al. Neurocognitive and somatic stabilization in pediatric patients with severe mucopolysaccharidosis type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial. Orphanet J Rare Dis. 2018 Jul 5;13(1):110.
   PubMedGoogle Scholar
• Rip J, Schenk G, De Boer A. Differential receptor-mediated drug targeting to the diseased brain. Expert Opin Drug Deliv. 2009;6(3):227–237.
   PubMed Web of Science ®Google Scholar
• Shukla RK, Tiwari A. Carbohydrate molecules: an expanding horizon in drug delivery and biomedicine. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2011;28:255–292.
   PubMed Web of Science ®Google Scholar
• Chen F, Huang G, Huang H. Sugar ligand-mediated drug delivery. Future Med Chem. 2020;12(2):161–171.
   PubMed Web of Science ®Google Scholar
• Holman GD. Chemical biology probes of mammalian GLUT structure and function. Biochem J. 2018;475(22):3511–3534.
   PubMedGoogle Scholar
• Anraku Y, Kuwahara H, Fukusato Y, et al. Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain. Nat Commun. 2017 Oct 17;8(1):1001.
   PubMedGoogle Scholar
• Zhang CX, Zhao WY, Liu L, et al. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment. Oncotarget. 2015 Oct 20;6(32):32681–32700.
   PubMedGoogle Scholar
• Agrawal P, Singh RP, Sonali, et al. TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy. Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:167–176. 10.1016/j.msec.2017.02.008
   PubMed Web of Science ®Google Scholar
• Bao Q, Hu P, Xu Y, et al. Simultaneous blood-brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles. ACS Nano. 2018 Jul 24;12(7):6794–6805.
   PubMed Web of Science ®Google Scholar
• Cui Y, Xu Q, Chow PK, et al. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials. 2013 Nov;34(33):8511–8520.
   PubMed Web of Science ®Google Scholar
• Di Mauro PP, Cascante A, Brugada Vilà P, et al. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma. Int J Pharm. 2018 Dec 20;553(1–2):169–185.
   PubMedGoogle Scholar
• Fu S, Liang M, Wang Y, et al. Dual-modified novel biomimetic nanocarriers improve targeting and therapeutic efficacy in glioma. ACS Appl Mater Interfaces. 2019 Jan 16;11(2):1841–1854.
   PubMed Web of Science ®Google Scholar
• Jiang X, Xin H, Ren Q, et al. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials. 2014 Jan;35(1):518–529.
   PubMed Web of Science ®Google Scholar
• Pardridge WM, Boado RJ, Giugliani R, et al. Plasma pharmacokinetics of valanafusp alpha, a human insulin receptor antibody-iduronidase fusion protein, in patients with mucopolysaccharidosis type I. BioDrugs. 2018 Apr;32(2):169–176.
   PubMed Web of Science ®Google Scholar
• Patil R, Portilla-Arias J, Ding H, et al. Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid). Pharm Res. 2010 Nov;27(11):2317–2329.
   PubMed Web of Science ®Google Scholar
• Porru M, Zappavigna S, Salzano G, et al. Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. Oncotarget. 2014 Nov 15;5(21):10446–10459.
   PubMedGoogle Scholar
• Shen J, Zhao Z, Shang W, et al. Fabrication and evaluation a transferrin receptor targeting nano-drug carrier for cerebral infarction treatment. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):192–200.
   PubMed Web of Science ®Google Scholar
• Shen Y, Cao B, Snyder NR, et al. ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood-brain barrier. J Nanobiotechnology. 2018 Feb 13;16(1):13.
   PubMedGoogle Scholar
• Wang W, Lin X, Dong X, et al. A multi-target theranostic nano-composite against Alzheimer’s disease fabricated by conjugating carbon dots and triple-functionalized human serum albumin. Acta Biomater. 2022 Aug;148:298–309.
   PubMed Web of Science ®Google Scholar
• Xie J, Gonzalez-Carter D, Tockary TA, et al. Dual-sensitive nanomicelles enhancing systemic delivery of therapeutically active antibodies specifically into the brain. ACS Nano. 2020 Jun 23;14(6):6729–6742.
   PubMed Web of Science ®Google Scholar
• Syková E, Nicholson C. Diffusion in brain extracellular space. Physiol Rev. 2008 Oct;88(4):1277–1340.
   PubMed Web of Science ®Google Scholar
• Wang A, Wang R, Cui D, et al. The drainage of interstitial fluid in the deep brain is controlled by the integrity of myelination. Aging Dis. 2019 Oct;10(5):937–948.
   PubMed Web of Science ®Google Scholar
• Wang R, Han H, Shi K, et al. The alteration of brain interstitial fluid drainage with myelination development. Aging Dis. 2021 Oct;12(7):1729–1740.
   PubMed Web of Science ®Google Scholar
• Gitler AD, Lu MM, Epstein JA. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev Cell. 2004 Jul;7(1):107–116.
   PubMed Web of Science ®Google Scholar
• Torres-Vazquez J, Gitler AD, Fraser SD, et al. Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell. 2004 Jul;7(1):117–123.
   PubMed Web of Science ®Google Scholar
• Xianjie Cai QH, Wang W, Chunlin L, et al. Epidural pulsation accelerates the drainage of brain interstitial fluid. Aging Dis. 2022. DOI:10.14336/AD.2022.0609
   Web of Science ®Google Scholar
• Zanotti-Fregonara P, Leroy C, Roumenov D, et al. Kinetic analysis of [11C]befloxatone in the human brain, a selective radioligand to image monoamine oxidase A. EJNMMI Res. 2013 Nov 25;3(1):78.
   PubMedGoogle Scholar
• Bourasset F, Auvity S, Thorne RG, et al. Brain distribution of drugs: brain morphology, delivery routes, and species differences. Handb Exp Pharmacol. 2022;273:97–120.
   PubMedGoogle Scholar
• Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012 Nov;32(11):1959–1972.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zou Y, Feng C, et al. Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy. Nano Lett. 2020 Mar 11;20(3):1637–1646.
   PubMed Web of Science ®Google Scholar
• Paviolo C, Cognet L. Near-infrared nanoscopy with carbon-based nanoparticles for the exploration of the brain extracellular space. Neurobiol Dis. 2021 Jun;153:105328.
   PubMed Web of Science ®Google Scholar
• Lau LW, Cua R, Keough MB, et al. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci. 2013 Oct;14(10):722–729.
   PubMed Web of Science ®Google Scholar
• Hrabetova S, Nicholson C. Contribution of dead-space microdomains to tortuosity of brain extracellular space. Neurochem Int. 2004 Sep;45(4):467–477.
   PubMed Web of Science ®Google Scholar
• KT FJ. Drug “diffusion” within the brain . Ann N Y Acad Sci. 1988;531:29–39.
   PubMed Web of Science ®Google Scholar
• Godin AG, Varela JA, Gao Z, et al. Single-nanotube tracking reveals the nanoscale organization of the extracellular space in the live brain. Nat Nanotechnol. 2017 Mar;12(3):238–243.
   PubMed Web of Science ®Google Scholar
• Tonnesen J, Inavalli V, Nagerl UV. Super-resolution imaging of the extracellular space in living brain tissue. Cell. 2018 Feb 22;172(5):1108–1121 e15.
   PubMed Web of Science ®Google Scholar
• Soria FN, Miguelez C, Penagarikano O, et al. Current techniques for investigating the brain extracellular space. Front Neurosci. 2020;14:570750.
   PubMed Web of Science ®Google Scholar
• Tao CNPK-ZL. Brain extracellular space as a diffusion barrier. Comput Visual Sci. 2011;14(7):309–325.
   PubMedGoogle Scholar
• Stern P. Tracking extracellular space in the brain. Science. 2016 Dec 23;354(6319):1547–1548.
   PubMedGoogle Scholar
• Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013 Oct 18;342(6156):373–377.
   PubMed Web of Science ®Google Scholar
• Mansor NI, Nordin N, Mohamed F, et al. Crossing the blood-brain barrier: a review on drug delivery strategies for treatment of the central nervous system diseases. Curr Drug Deliv. 2019;16(8):698–711.
   PubMed Web of Science ®Google Scholar
• Misra A, Ganesh S, Shahiwala A, et al. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003 May-Aug;6(2):252–273.
   PubMed Web of Science ®Google Scholar
• Hoshyar N, Gray S, Han H, et al. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine (Lond). 2016 Mar;11(6):673–692.
   PubMed Web of Science ®Google Scholar
• Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009 Jun;40(6):2244–2250.
   PubMed Web of Science ®Google Scholar
• Han H, Li K, Yan J, et al. An in vivo study with an MRI tracer method reveals the biophysical properties of interstitial fluid in the rat brain. Sci China Life Sci. 2012 Sep;55(9):782–787.
   PubMed Web of Science ®Google Scholar
• Han HB. In vivo quantitative measurement of diffusion parameters in brain extracellular space of rat by using magnetic resonance imaging. Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Oct 18;44(5):770–775.
   PubMedGoogle Scholar
• Zuo LLK, Han H. Comparative analysis by magnetic resonance imaging of extracellular space diffusion and interstitial fluid flow in the rat striatum and thalamus. Appl Magn Reson. 2015;46(6):623–632.
   Web of Science ®Google Scholar
• Han H, Shi C, Fu Y, et al. A novel MRI tracer-based method for measuring water diffusion in the extracellular space of the rat brain. IEEE J Biomed Health Inform. 2014 May;18(3):978–983.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Drug transport in brain via the cerebrospinal fluid. Fluids Barriers CNS. 2011 Jan 18;8(1):7.
   PubMedGoogle Scholar
• Shi CLY, Han H. Transportation in the interstitial space of the brain can be regulated by neuronal excitation. Sci Rep. 2015;3(5):17673.
   Google Scholar
• Naseri Kouzehgarani PK G, Bolin SE, Reilly EB, et al. Biodistribution analysis of an anti-egfr antibody in the rat brain: validation of CSF microcirculation as a viable pathway to circumvent the blood-brain barrier for drug delivery. Pharmaceutics. 2022;14(7):1441.
   PubMed Web of Science ®Google Scholar
• Sykova E, Vorisek I, Antonova T, et al. Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer’s disease. Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):479–484.
   PubMed Web of Science ®Google Scholar
• Hong S, Ostaszewski BL, Yang T, et al. Soluble Abeta oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes. Neuron. 2014 Apr 16;82(2):308–319.
   PubMed Web of Science ®Google Scholar
• Jessen NA, Munk AS, Lundgaard I, et al. The glymphatic system: a beginner’s guide. Neurochem Res. 2015 Dec;40(12):2583–2599.
   PubMed Web of Science ®Google Scholar
• Thrane AS, Rangroo Thrane V, Nedergaard M. Drowning stars: reassessing the role of astrocytes in brain edema. Trends Neurosci. 2014 Nov;37(11):620–628.
   PubMed Web of Science ®Google Scholar
• Yue X, Mei Y, Zhang Y, et al. New insight into Alzheimer’s disease: light reverses Abeta-obstructed interstitial fluid flow and ameliorates memory decline in APP/PS1 mice. Alzheimers Dement (N Y). 2019;5(1):671–684.
   PubMedGoogle Scholar
• Cummings J, Lee G, Ritter A, et al. Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement (N Y). 2018;4:195–214. DOI:10.1016/j.trci.2018.03.009.
   PubMedGoogle Scholar
• Mangialasche F, Solomon A, Winblad B, et al. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol. 2010 Jul;9(7):702–716.
   PubMed Web of Science ®Google Scholar
• Tran HT, Chung CH, Iba M, et al. Α-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration. Cell Rep. 2014 Jun 26;7(6):2054–2065.
   PubMed Web of Science ®Google Scholar
• Moretto E, Stuart S, Surana S, et al The role of extracellular matrix components in the spreading of pathological protein aggregates. Front Cell Neurosci. 2022;16:844211.
   PubMed Web of Science ®Google Scholar
• Soria FN, Paviolo C, Doudnikoff E, et al. Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling. Nat Commun. 2020 Jul 10;11(1):3440.
   PubMed Web of Science ®Google Scholar
• Lv D, Li J, Li H, et al. Imaging and quantitative analysis of the interstitial space in the caudate nucleus in a rotenone-induced rat model of Parkinson’s disease using tracer-based MRI. Aging Dis. 2017 Feb;8(1):1–6.
   PubMed Web of Science ®Google Scholar
• Zámecník J, Vargová L, Homola A, et al. Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours. Neuropathol Appl Neurobiol. 2004 Aug;30(4):338–350.
   PubMed Web of Science ®Google Scholar
• Syková E, Vargová L. Extrasynaptic transmission and the diffusion parameters of the extracellular space. Neurochem Int. 2008 Jan;52(1–2):5–13.
   PubMed Web of Science ®Google Scholar
• Verkman AS. Diffusion in the extracellular space in brain and tumors. Phys Biol. 2013 Aug;10(4):045003.
   PubMed Web of Science ®Google Scholar
• Papadopoulos MC, Binder DK, Verkman AS. Enhanced macromolecular diffusion in brain extracellular space in mouse models of vasogenic edema measured by cortical surface photobleaching. FASEB J. 2005 Mar;19(3):425–427.
   PubMedGoogle Scholar
• Guan X, Wang W, Wang A, et al. Brain interstitial fluid drainage alterations in glioma-bearing rats. Aging Dis. 2018;9(2):228–234.
   Web of Science ®Google Scholar
• Li K, Han H, Zhu K, et al. Real-time magnetic resonance imaging visualization and quantitative assessment of diffusion in the cerebral extracellular space of C6 glioma-bearing rats. Neurosci Lett. 2013 May 24;543:84–89. 10.1016/j.neulet.2013.02.071
   PubMed Web of Science ®Google Scholar
• Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012 Jan;34(1):43–62.
   PubMed Web of Science ®Google Scholar
• Ghorbani S, Yong VW. The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis. Brain. 2021 Aug 17;144(7):1958–1973.
   PubMedGoogle Scholar
• Back SA, Tuohy TM, Chen H, et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med. 2005 Sep;11(9):966–972.
   PubMed Web of Science ®Google Scholar
• Mohan H, Krumbholz M, Sharma R, et al. Extracellular matrix in multiple sclerosis lesions: fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathol. 2010 Sep;20(5):966–975.
   PubMed Web of Science ®Google Scholar
• Simon MJ, Iliff JJ. Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease. Biochim Biophys Acta. 2016 Mar;1862(3):442–451.
   PubMed Web of Science ®Google Scholar
• Simon M, Wang MX, Ismail O, et al. Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid beta plaque formation in mice. Alzheimers Res Ther. 2022 Apr 26;14(1):59.
   PubMed Web of Science ®Google Scholar
• Teng Z, Wang A, Wang P, et al. The effect of aquaporin-4 knockout on interstitial fluid flow and the structure of the extracellular space in the deep brain. Aging Dis. 2018 Oct;9(5):808–816.
   PubMed Web of Science ®Google Scholar
• Tosi G, Thomas Duskey J, Angela Vandelli M, et al. Nanomedicines for brain diseases: where we are and where we are going. Ther Deliv. 2021 Sep;12(9):631–635.
   PubMed Web of Science ®Google Scholar
• Emamgholizadeh Minaei S, Khoei S, Khoee S, et al. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma. Int J Biochem Cell Biol. 2019 Mar;108:72–83.
   PubMed Web of Science ®Google Scholar
• Zhao P, Wang Y, Kang X, et al. Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy. Chem Sci. 2018 Mar 14;9(10):2674–2689.
   PubMed Web of Science ®Google Scholar
• Sukumar UK, Bose RJC, Malhotra M, et al. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Biomaterials. 2019 Oct;218:119342.
   PubMed Web of Science ®Google Scholar
• Liu H, Dong X, Liu F, et al. Iminodiacetic acid-conjugated nanoparticles as a bifunctional modulator against Zn(2+)-mediated amyloid β-protein aggregation and cytotoxicity. J Colloid Interface Sci. 2017 Nov 1;505:973–982. DOI:10.1016/j.jcis.2017.06.093.
   PubMed Web of Science ®Google Scholar
• Jung H, Chung YJ, Wilton R, et al. Silica nanodepletors: targeting and clearing Alzheimer’s β‐amyloid plaques. Adv Funct Mater. 2020;30(15):1910475.
   Web of Science ®Google Scholar
• Han G, Bai K, Yang X, et al. “Drug-Carrier” synergy therapy for Amyloid- β clearance and inhibition of tau phosphorylation via biomimetic lipid nanocomposite assembly. Adv Sci. 2022;9(14):2106072.
   Web of Science ®Google Scholar
• Arisoy S, Sayiner O, Comoglu T, et al. In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery. Pharm Dev Technol. 2020 Jul;25(6):735–747.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu W, Xiong S, et al. Highly stabilized nanocrystals delivering ginkgolide B in protecting against the Parkinson’s disease. Int J Pharm. 2020 Mar 15;577:119053. 10.1016/j.ijpharm.2020.119053
   PubMed Web of Science ®Google Scholar
• Chen T, Liu W, Xiong S, et al. Nanoparticles mediating the sustained puerarin release facilitate improved brain delivery to treat Parkinson’s disease. ACS Appl Mater Interfaces. 2019 Dec 4;11(48):45276–45289.
   PubMed Web of Science ®Google Scholar
• Baumhefner RW, Leng M. Standard dose weekly intramuscular beta interferon-1a may be inadequate for some patients with multiple sclerosis: a 19-year clinical experience using twice a week dosage. Neurol Ther. 2022 Jul 7;113. 10.1007/s40120-022-00377-1
   PubMed Web of Science ®Google Scholar
• van Ballegooijen H, van der Hiele K, Enzinger C, et al. The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a. eNeurologicalSci. 2022 Sep;28:100409.
   PubMedGoogle Scholar
• Fodor-Kardos A, Kiss ÁF, Monostory K, et al. Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles. RSC Adv. 2020;10(27):15893–15900.
   PubMed Web of Science ®Google Scholar
• Greer JM, Trifilieff E, Pender MP. Correlation between anti-myelin proteolipid protein (PLP) antibodies and disease severity in multiple sclerosis patients with PLP response-permissive HLA types. Front Immunol. 2020;11:1891.
   PubMed Web of Science ®Google Scholar
• Lima AF, Amado IR, Pires LR. Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles loaded with proteolipid protein (PLP)-exploring a new administration route. Polymers (Basel). 2020 Dec 21;12(12). DOI:10.3390/polym12123063.
   Web of Science ®Google Scholar
• Wong XY, Sena-Torralba A, Alvarez-Diduk R, et al. Nanomaterials for nanotheranostics: tuning their properties according to disease needs. ACS nano. 2020;14(3):2585–2627.
   PubMed Web of Science ®Google Scholar
• Najahi-Missaoui W, Arnold RD, Cummings BS. Safe nanoparticles: are we there yet?. Int J Mol Sci. 2020 Dec 31;221. DOI:10.3390/ijms22010385.
   PubMed Web of Science ®Google Scholar
• Awasthi R, Roseblade A, Hansbro PM, et al. Nanoparticles in cancer treatment: opportunities and obstacles. Curr Drug Targets. 2018;19(14):1696–1709.
   PubMed Web of Science ®Google Scholar
• Chen KS, Chen R. Invasive and noninvasive brain stimulation in Parkinson’s disease: clinical effects and future perspectives. Clin Pharmacol Ther. 2019 Oct;106(4):763–775.
   PubMed Web of Science ®Google Scholar
• He QY, Han HB, Xu FJ, et al. Imaging and quantitative measurement of brain extracellular space using MRI Gd-DTPA tracer method. Beijing Da Xue Xue Bao Yi Xue Ban. 2010 Apr 18;42(2):188–191.
   PubMedGoogle Scholar
• Xu F, Hongbin H, Yan J, et al. Greatly improved neuroprotective efficiency of citicoline by stereotactic delivery in treatment of ischemic injury. Drug Deliv. 2011 Sep-Oct;18(7):461–467.
   PubMed Web of Science ®Google Scholar
• Fan C, Tian F, Zhao X, et al. The effect of thymoquinone on the characteristics of the brain extracellular space in transient middle cerebral artery occlusion rats. Biol Pharm Bull. 2020;43(9):1306–1314.
   PubMed Web of Science ®Google Scholar
• Deplanque D, Lavallee PC, Labreuche J, et al. Cerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients: a case-control study. Int J Stroke. 2013 Aug;8(6):413–421.
   PubMed Web of Science ®Google Scholar
• Hua S. Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Front Pharmacol. 2019;10:1328.
   PubMed Web of Science ®Google Scholar
• Bhirud PH, Kate JA. Perioperative sublingual levodopa in Parkisnon’s Disease: a useful alternative!. Indian J Anaesth. 2017 May;61(5):432–434.
   PubMedGoogle Scholar
• Kanazawa T. Development of noninvasive drug delivery systems to the brain for the treatment of brain/central nervous system diseases. Yakugaku Zasshi. 2018;138(4):443–450.
   PubMed Web of Science ®Google Scholar
• Abdul Razzak R, Florence GJ, Gunn-Moore FJ. Approaches to CNS drug delivery with a focus on transporter-mediated transcytosis. Int J Mol Sci. 2019 Jun 25;20 12. DOI:10.3390/ijms20123108.
   PubMed Web of Science ®Google Scholar
• Hennessy M, Hamblin MR. Photobiomodulation and the brain: a new paradigm. J Opt. 2017 Jan;19(1):013003.
   PubMed Web of Science ®Google Scholar
• Stepanov YV, Golovynska I, Zhang R, et al. Near-infrared light reduces beta-amyloid-stimulated microglial toxicity and enhances survival of neurons: mechanisms of light therapy for Alzheimer’s disease. Alzheimers Res Ther. 2022 Jun 18;14(1):84.
   PubMed Web of Science ®Google Scholar
• Johnstone DM, Moro C, Stone J, et al. Turning on lights to stop neurodegeneration: the potential of near infrared light therapy in Alzheimer’s and Parkinson’s disease. Front Neurosci. 2015;9:500.
   PubMed Web of Science ®Google Scholar
• Henderson TA, Morries LD. Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?. Neuropsychiatr Dis Treat. 2015;11:2191–2208.
   PubMed Web of Science ®Google Scholar
• Iaccarino HF, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230–235.
   PubMed Web of Science ®Google Scholar
• Hamblin MR. Photobiomodulation for Alzheimer’s disease: has the light dawned?. Photonics. 2019 Sep;6(3).
   PubMed Web of Science ®Google Scholar
• Enengl J, Hamblin MR, Dungel P. Photobiomodulation for Alzheimer’s disease: translating basic research to clinical application. J Alzheimers Dis. 2020;75(4):1073–1082.
   PubMed Web of Science ®Google Scholar
• Terman M. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry. 1999;60(11):799–808.
   PubMed Web of Science ®Google Scholar
• Huang N, Yao D, Jiang W, et al. Safety and efficacy of 630-nm red light on cognitive function in older adults with mild to moderate Alzheimer’s disease: protocol for a randomized controlled study. Front Aging Neurosci. 2020;12:143.
   PubMed Web of Science ®Google Scholar
• Salehpour F, Farajdokht F, Mahmoudi J, et al. Photobiomodulation and coenzyme Q10 treatments attenuate cognitive impairment associated with model of transient global brain ischemia in artificially aged mice. Front Cell Neurosci. 2019;13:74.
   PubMed Web of Science ®Google Scholar
• Salehpour F, Hamblin MR, DiDuro JO. Rapid reversal of cognitive decline, olfactory dysfunction, and quality of life using multi-modality photobiomodulation therapy: case report. Photobiomodul Photomed Laser Surg. 2019;37(3):159–167.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yue X, Luo H, et al. Illumination with 630 nm red light reduces oxidative stress and restores memory by photo-activating catalase and formaldehyde dehydrogenase in SAMP8 mice. Antioxid Redox Signal. 2019 Apr 10;30(11):1432–1449.
   PubMed Web of Science ®Google Scholar
• Fei X, Zhang Y, Mei Y, et al. Degradation of FA reduces abeta neurotoxicity and Alzheimer-related phenotypes. Mol Psychiatry. 2020 Dec 16;26(10). 10.1038/s41380-020-00929-7
   PubMed Web of Science ®Google Scholar
• Luan X, Pan Y, Gao Y, et al. Recent near-infrared light-activated nanomedicine toward precision cancer therapy. J Mater Chem B. 2021 Sep 15;9(35):7076–7099.
   PubMed Web of Science ®Google Scholar
• Wang C, Dai C, Hu Z, et al. Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms. Nanoscale Horiz. 2019 Mar 1;4(2):415–425.
   PubMed Web of Science ®Google Scholar
• Xiong H, Li X, Kang P, et al. Near-infrared light triggered-release in deep brain regions using ultra-photosensitive nanovesicles. Angew Chem Int Ed Engl. 2020 May 25;59(22):8608–8615.
   PubMed Web of Science ®Google Scholar
• Black CE, Zhou E, DeAngelo C, et al. Cyanine nanocage activated by near-IR light for the targeted delivery of cyclosporine A to traumatic brain injury sites. Mol Pharm. 2020 Dec 7;17(12):4499–4509.
   PubMedGoogle Scholar
• Farokhi M, Mottaghitalab F, Saeb MR, et al. Functionalized theranostic nanocarriers with bio-inspired polydopamine for tumor imaging and chemo-photothermal therapy. J Control Release. 2019 Sep 10;309:203–219.
   PubMed Web of Science ®Google Scholar
• Ragelle H, Danhier F, Préat V, et al. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures. Expert Opin Drug Deliv. 2017;14(7):851–864.
   PubMed Web of Science ®Google Scholar
• Bhavna MS, Ali M, Baboota S, et al. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev Ind Pharm. 2014;40(2):278–287.
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–760.
   PubMed Web of Science ®Google Scholar
• Rip J, Schenk GJ, de Boer AG. Differential receptor-mediated drug targeting to the diseased brain. Expert Opin Drug Deliv. 2009 Mar;6(3):227–237.
   PubMed Web of Science ®Google Scholar
• Hrabetova S, Cognet L, Rusakov DA, et al. Unveiling the extracellular space of the brain: from super-resolved microstructure to in vivo function. J Neurosci. 2018 Oct 31;38(44):9355–9363.
   PubMed Web of Science ®Google Scholar
• Salamanna F, Gambardella A, Contartese D, et al. Nano-based biomaterials as drug delivery systems against osteoporosis: a systematic review of preclinical and clinical evidence. Nanomaterials (Basel). 2021 Feb 19;11(2). 10.3390/nano11020530
   PubMedGoogle Scholar